EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Predictors of chronic arthralgia after chikungunya virus infection: a systematic review and meta-analysis

Lucas Bussiki Corrêa da Costa Kotecki, Vitória Diniz de Medeiros, Mariana Bussiki Corrêa da Costa Kotecki, Bianca Gabriela Tavares Castiglioni, Miguel Chaves Lenzi, Isadora Pasqualette Silva, Rafaela Coelho Duarte, João Vitor Kayser de Souza, Cláudia Figueredo Nascimento Salomão Santos, Gabriela Stutz F Moreira, José Aldair Kotecki, Lucas Pompeu Salomão, Tatiana Fortes de Oliveira

Journal of Travel Medicine · 2026-10-30 · 33 (7)

DOI: 10.1093/jtm/taag078 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Chikungunya is an expanding global health threat, with chronic arthralgia representing the main long-term driver of disability. Although many studies have assessed post-chikungunya outcomes, evidence remains fragmented and contradictory. We aimed to identify reproducible predictors of chronic arthralgia (≥3 months) after laboratory-confirmed chikungunya and to distinguish stable prognostic signals from context-dependent associations. Methods We searched PubMed, Embase, Cochrane Library and BVS/LILACS from inception to 6 February 2026, without restrictions. Eligible studies compared participants with and without chronic arthralgia at follow-up and reported extractable baseline or acute-phase factors. Two reviewers independently screened records, extracted data and assessed risk of bias using QUIPS. Random-effects restricted maximum likelihood meta-analyses pooled odds ratios and mean differences, with subgroup analyses by follow-up window. PROSPERO: CRD420251169320. Results Of 1784 records, 29 studies were included, comprising 4108 participants: 1878 with chronic arthralgia and 2230 without. After harmonization, 22 predictors were meta-analysed. The most consistent associations were female sex [odds ratio (OR) 2.08, 95% confidence interval (CI) 1.77–2.46; I2 = 8.3%], comorbidity presence (1.99, 1.55–2.55; I2 = 0%) and high blood pressure (1.52, 1.13–2.04; I2 = 33.4%). In contrast, several acute-phase manifestations and treatment-related markers showed less stable, timing-dependent or study-sensitive associations. Overall risk of bias was high in most studies and moderate in the remainder. Conclusions Chronic post-chikungunya arthralgia was most reproducibly associated with readily identifiable baseline host factors, rather than with a uniform acute-severity phenotype. These findings suggest that risk stratification should not rely only on acute symptom burden, and that pre-existing vulnerability may define a clinically important high-risk group. Point-of-care identification of patients with these characteristics could support prioritization of follow-up and resource allocation during outbreaks, inform post-outbreak surveillance and guideline development, and may guide future burden-based vaccination strategies in endemic settings.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →